240 related articles for article (PubMed ID: 16235158)
1. InDuo, a novel combined insulin injection and blood glucose monitoring device - effective and save as other devices, and patient preference.
Haupt A; Berg B; Paschen P; Dreyer M; Häring HU; Smedegaard J; Skovlund SE; Matthaei S
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):541-4. PubMed ID: 16235158
[TBL] [Abstract][Full Text] [Related]
2. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
[TBL] [Abstract][Full Text] [Related]
4. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
[TBL] [Abstract][Full Text] [Related]
5. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
[TBL] [Abstract][Full Text] [Related]
6. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.
Ligthelm RJ; Mouritzen U; Lynggaard H; Landin-Olsson M; Fox C; le Devehat C; Romero E; Liebl A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):511-9. PubMed ID: 17115349
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of bedside glucose measurement from three glucometers in critically ill patients.
Hoedemaekers CW; Klein Gunnewiek JM; Prinsen MA; Willems JL; Van der Hoeven JG
Crit Care Med; 2008 Nov; 36(11):3062-6. PubMed ID: 18824915
[TBL] [Abstract][Full Text] [Related]
8. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
[TBL] [Abstract][Full Text] [Related]
9. The Accu-Chek Mobile blood glucose monitoring system used under controlled conditions meets ISO 15197 standards in the hands of diabetes patients.
Sachse D; Bolstad N; Jonsson M; Sæves I; Johansson CB; Delezuch W; Hagve M; Hardang IM; Isaksson HS; Ivarsson A; Lehto L; Keikkala E; Mattsson N; Ranta JK; Stavelin A; Sudmann AA; Varsi K
Scand J Clin Lab Invest; 2012 Sep; 72(5):374-9. PubMed ID: 22900743
[TBL] [Abstract][Full Text] [Related]
10. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
11. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
13. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
[TBL] [Abstract][Full Text] [Related]
14. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
Simon B; Treat V; Marco C; Rosenberg D; Joseph J; Hipszer B; Li Y; Chervoneva I; Padron-Massara L; Jabbour S
Int J Clin Pract; 2008 Dec; 62(12):1858-63. PubMed ID: 19166434
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the OneTouch® Delica™: a low-pain lancing system for self-monitoring of blood glucose.
Ginsberg BH; Shemain A; Pines MK; Wallace DA; Pineau M
Postgrad Med; 2011 Jul; 123(4):92-8. PubMed ID: 21680993
[TBL] [Abstract][Full Text] [Related]
16. Variability of blood glucose levels in patients with type 1 diabetes mellitus on intensified insulin regimens.
Moberg EA; Lins PE; Adamson UK
Diabete Metab; 1994; 20(6):546-52. PubMed ID: 7713278
[TBL] [Abstract][Full Text] [Related]
17. Effect of adverse storage conditions on performance of glucometer test strips.
Bamberg R; Schulman K; MacKenzie M; Moore J; Olchesky S
Clin Lab Sci; 2005; 18(4):203-9. PubMed ID: 16315736
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
Dornhorst A; Lüddeke HJ; Sreenan S; Koenen C; Hansen JB; Tsur A; Landstedt-Hallin L
Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
[TBL] [Abstract][Full Text] [Related]
19. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
[TBL] [Abstract][Full Text] [Related]
20. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
